In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: HealthStream’s current price trades 31% below a high-confidence fair value estimate, indicating potential undervaluation supported by robust DCF and P/E valuations. Financial health scores reveal moderate liquidity, profitability, and growth but strong leverage, underscoring risk in capital structure. Monte Carlo results show high volatility with a notable 32% downside risk, reflecting significant uncertainty despite a median value above current price.